All In MedTech

Device Trial Radar · NCT07948330

rTMS for Incontinence After Prostate Treatment

Non-invasive Brain Neuromodulation in Men for Management of Incontinence After Prostate Treatment: a Proof-of-concept Study

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

23

Planned (sponsor's estimate)

Start

Sep 16, 2026

Primary completion

Oct 1, 2027

Study completion Oct 1, 2027

Sponsor

Lead sponsor
The Methodist Hospital Research InstituteAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 19, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Other
FDA-regulated device
Yes
Who can join
Male only, from 22 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Incontinence after prostate treatment (IPT) affects up to 25% of men following radical prostatectomy or other prostate therapies, primarily resulting from sphincteric weakness and impaired neuromuscular control. Current management options, including behavioral therapy and surgical implants, are often limited by modest effectiveness or invasiveness. Emerging neuroimaging evidence demonstrates that the pelvic supplementary motor area (pSMA) in the brain plays a critical regulatory role in controlling pelvic floor muscles and urethral sphincter activity. This proof-of-concept, prospective, randomized clinical trial aims to evaluate the safety, tolerability, acceptability, and procedural feasibility of targeting the pSMA using non-invasive repetitive transcranial magnetic stimulation (rTMS) in adult males with IPT, alongside a cohort of continent controls. A total of 23 participants will be enrolled (targeting 10 evaluable IPT subjects and 10 continent controls). Participants undergo baseline fMRI using a natural bladder filling protocol, and a randomized, single-session neuronavigated rTMS protocol with concurrent pelvic floor electromyography (EMG) and functional Magnetic Resonance Imaging (fMRI) to evaluate physiological and neurofunctional changes. Safety and adverse events are monitored closely through a 1-month virtual follow-up visit. Findings from this study will establish foundational evidence for cortical modulation of pelvic floor control in IPT. Additionally, these results will guide the design of a future larger, clinical trial to optimize rTMS parameters and integrate brain neuromodulation into post-prostate treatment rehabilitation strategies.

Conditions

  • Urinary Incontinence
  • Prostate Treatment
  • Incontinence After Prostate Treatment

Interventions

  • Magstim - rTMS systemDevice

    The Magstim Rapid2 system is a magnetic stimulation system capable of selectively inducing, modulating, or suppressing neuronal activity. This rTMS device will be used along with the D70 Alpha Coil package, which includes an active coil ideal for focal rTMS. Utilizing the StimGuide navigation system, the investigators will accurately target the pelvic supplementary motor area (pSMA). The Magstim Rapid2 system is used in this study to deliver either high-frequency (excitatory) or low-frequency (inhibitory) rTMS to assess physiological and neurofunctional effects on continence control in men with incontinence after prostate treatment (IPT).

  • Baseline Imaging and QuestionnairesOther

    Non-interventional control consistent of questionnaires and baseline brain functional MRI (fMRI) with no rTMS stimulation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Recruitment and Retention RateTime frame: From enrollment through the 1-month follow-up visit (approximately 2 to 3 months total per participant)
  2. Acceptability of InterventionTime frame: Immediately after the single rTMS treatment session (Visit 4 : 3 weeks +/- 2 weeks after enrollment)
  3. Adverse EventsTime frame: From informed consent through the 1-month virtual follow-up visit

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Houston Methodist Hospital

    Houston, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.